Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were ...

Older adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who started a GLP-1 receptor agonist had a ...

Obesity is the epidemic of the 21st century, affecting so many people around us. Dr. Christos Mantzoros the work of his team ...

GLP-1 receptor agonists affect metabolic, inflammatory, and neuronal survival pathways implicated in Parkinson’s disease, ...

Two common GLP-1 weight loss drugs have been linked to a brain condition that can cause permanent brain damage and become deadly. GLP-1s work by slowing down digestion, making us feel full for longer.

Mochi Health lowers costs for compounded semaglutide and tirzepatide while adding new blood testing services.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Researchers at the University of California, Berkeley, found that ...

GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help people live longer. The idea that these medications ...

A new opinion article argues that inflammation may be the missing link explaining both the potential suicide risk and the ...

The GLP-1 hormone plays a pivotal role in regulating appetite and metabolic pace, signaling fullness after meals and supporting healthy glucose uptake. However, modern dietary patterns, chronic stress ...

GLP-1 agonists can help treat different components of polyendocrine metabolic ovarian syndrome (PMOS), as well as related ...